ANALYSIS OF EFFECTIVENESS, SAFETY AND COST OF DIFFERENT DOSES OF RITUXIMAB IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Mena-Vazquez, N. [1 ]
Manrique-Arija, S. [1 ]
Ordonez-Canizares, M. C. [1 ]
Domic, C. [1 ]
Urena-Garnica, I. [1 ]
Barco, C. M. Romero [1 ]
Jimenez-Nunez, F. G. [1 ]
Rojas-Gimenez, M. [1 ]
Fuego, C. [1 ]
Cano-Garcia, L. [1 ]
Irigoyen-Oyarzabal, M. V. [1 ]
Coret, V. [1 ]
Belmonte-Lopez, A. [1 ]
Fernandez-Nebro, A. [1 ]
机构：
[1] Univ Malaga, Hosp Reg Malaga, Inst Invest Biomed Malaga IBIMA, UGC Reumatol, Malaga, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0177
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [11] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Benucci, Maurizio
    Saviola, Gianantonio
    Baiardi, Paola
    Manfredi, Mariangela
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) : 1465 - 1469
  • [12] Analysis of effectiveness, safety and optimization of tocilizumab in a cohort of patients with rheumatoid arthritis in clinical practice
    Mena-Vazquez, Natalia
    Manrique-Arija, Sara
    Rojas-Gimenez, Marta
    Urena-Garnica, Inmaculada
    Jimenez-Nunez, Francisco G.
    Fernandez-Nebro, Antonio
    REUMATOLOGIA CLINICA, 2019, 15 (01): : 21 - 26
  • [13] RITUXIMAB IN RHEUMATOID ARTHRITIS, A MONOCENTRIC ANALYSIS OF EFFECTIVENESS
    Madureira, P.
    Vieira, R.
    Terroso, G.
    Aleixo, A.
    Fonseca, R.
    Goncalves, D.
    Pimenta, S.
    Bernardo, A.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 887 - 887
  • [14] RITUXIMAB AS FIRST CHOICE FOR PATIENTS WITH REFRACTORY RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND COST-EFFECTIVENESS ANALYSIS
    Ahmadiani, S.
    Nikfar, S.
    Karimi, S.
    Jamshidi, A. R.
    Kebriaeezadeh, A.
    Akbari-Sari, A.
    VALUE IN HEALTH, 2014, 17 (03) : A47 - A47
  • [15] COMPARATIVE STUDY OF RADIOLOGICAL AND THERAPEUTIC EFFECTS OF DIFFERENT DOSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kudryavceva, A.
    Lukina, G.
    Smirnov, A.
    Glukhova, S.
    Aronova, E.
    Gridneva, G.
    Kovalenko, P.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S360 - S360
  • [16] Effectiveness of Rituximab in rheumatoid arthritis
    Marti-Navarro, Marta
    Frias-Lopez, Carmen
    Gomez-Centeno, Toni
    Campos, Begona
    Humbert, Sarai
    Salvador, Roger
    Altimiras-Ruiz, Joan
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 728 - 729
  • [17] Cost-effectiveness of rituximab therapy for rheumatoid arthritis: A Pan-European analysis
    Kielhorn, A
    Rubbert, A
    Porter, D
    De Vita, S
    Brown, B
    Aristides, M
    Aultman, R
    Jost, F
    VALUE IN HEALTH, 2006, 9 (03) : A27 - A27
  • [18] Cost-effectiveness analysis of rituximab as a new therapeutic option for rheumatoid arthritis in the UK
    Porter, D
    Lewis, G
    Brown, B
    Diamantopoulos, A
    Kielhorn, A
    VALUE IN HEALTH, 2006, 9 (03) : A25 - A25
  • [19] Cost-Effectiveness Analysis of Two Rituximab Retreatment Regimens for Longstanding Rheumatoid Arthritis
    Quartuccio, Luca
    di Bidino, Rossella
    Ruggeri, Matteo
    Schiavon, Franco
    Biasi, Domenico
    Adami, Silvano
    Punzi, Leonardo
    Cicchetti, Americo
    de Vita, Salvatore
    ARTHRITIS CARE & RESEARCH, 2015, 67 (07) : 947 - 955
  • [20] SAFETY OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSOCIATED WITH BRONCHIECTASIS: RESULTS FROM A MULTICENTRE COHORT
    Yusof, Yusaiful
    Iqbal, Kundan
    Emery, Paul
    Kelly, Clive
    Dass, Shouvik
    RHEUMATOLOGY, 2016, 55 : 103 - 104
12345